April 2019

Editorial Commentary 
WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
Mikito Suzuki, Tomoyuki Hishida, Keisuke Asakura, Hisao Asamura
Mediastinum  
2019;
3:
12  
Editorial Commentary 
WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
Nobuyuki Takahashi, Chen Zhao, Arun Rajan
Mediastinum  
2019;
3:
11